Bank of Montreal’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297K Sell
3,959
-4,658
-54% -$299K ﹤0.01% 2782
2026
Q1
$486K Buy
8,617
+4,540
+111% +$296K ﹤0.01% 2411
2025
Q4
$327K Sell
4,077
-12,998
-76% -$873K ﹤0.01% 2538
2025
Q3
$832K Buy
17,075
+10,395
+156% +$643K ﹤0.01% 2035
2025
Q2
$498K Sell
6,680
-70,344
-91% -$4.66M ﹤0.01% 2282
2025
Q1
$4.89M Buy
77,024
+69,091
+871% +$4.7M ﹤0.01% 1178
2024
Q4
$619K Buy
7,933
+602
+8% +$48.4K ﹤0.01% 2105
2024
Q3
$585K Buy
7,331
+164
+2% +$13.2K ﹤0.01% 2309
2024
Q2
$636K Buy
7,167
+350
+5% +$30.8K ﹤0.01% 2268
2024
Q1
$582K Sell
6,817
-189
-3% -$14.8K ﹤0.01% 2347
2023
Q4
$617K Sell
7,006
-407
-5% -$35.2K ﹤0.01% 2360
2023
Q3
$669K Sell
7,413
-2,435
-25% -$217K ﹤0.01% 2271
2023
Q2
$839K Sell
9,848
-1,516
-13% -$128K ﹤0.01% 2279
2023
Q1
$943K Sell
11,364
-3,456
-23% -$280K ﹤0.01% 2078
2022
Q4
$1.19M Buy
14,820
+720
+5% +$57.9K ﹤0.01% 2089
2022
Q3
$1.1M Sell
14,100
-32,612
-70% -$2.34M ﹤0.01% 2122
2022
Q2
$3.06M Buy
46,712
+13,673
+41% +$809K ﹤0.01% 1682
2022
Q1
$2.03M Buy
33,039
+24,785
+300% +$1.35M ﹤0.01% 1924
2021
Q4
$446K Sell
8,254
-22,487
-73% -$1.37M ﹤0.01% 2476
2021
Q3
$2.18M Sell
30,741
-80,035
-72% -$5.05M ﹤0.01% 2023
2021
Q2
$7.49M Buy
110,776
+14,808
+15% +$1.05M ﹤0.01% 1413
2021
Q1
$10.9M Sell
95,968
-21,120
-18% -$2.61M 0.01% 967
2020
Q4
$14.7M Sell
117,088
-16,117
-12% -$1.74M 0.01% 833
2020
Q3
$12.5M Buy
133,205
+90,773
+214% +$7.93M 0.01% 754
2020
Q2
$3.69M Buy
42,432
+30,794
+265% +$3.11M ﹤0.01% 1323
2020
Q1
$1.16M Sell
11,638
-639
-5% -$69.3K ﹤0.01% 1648
2019
Q4
$1.41M Buy
12,277
+5,023
+69% +$608K ﹤0.01% 2063
2019
Q3
$915K Buy
7,254
+1,788
+33% +$227K ﹤0.01% 2120
2019
Q2
$658K Buy
5,466
+4,143
+313% +$408K ﹤0.01% 2266
2019
Q1
$116K Sell
1,323
-729
-36% -$66.3K ﹤0.01% 2994
2018
Q4
$205K Buy
2,052
+310
+18% +$32.6K ﹤0.01% 2565
2018
Q3
$200K Sell
1,742
-2,430
-58% -$252K ﹤0.01% 2750
2018
Q2
$375K Buy
4,172
+2,761
+196% +$233K ﹤0.01% 2458
2018
Q1
$103K Buy
1,411
+126
+10% +$8.64K ﹤0.01% 2953
2017
Q4
$74K Buy
1,285
+121
+10% +$6.37K ﹤0.01% 3120
2017
Q3
$52K Hold
1,164
﹤0.01% 3212
2017
Q2
$46K Buy
1,164
+54
+5% +$2.22K ﹤0.01% 3251
2017
Q1
$45K Buy
1,110
+333
+43% +$13K ﹤0.01% 3116
2016
Q4
$31K Sell
777
-107
-12% -$4.03K ﹤0.01% 3264
2016
Q3
$32K Hold
884
﹤0.01% 3184
2016
Q2
$25K Sell
884
-838
-49% -$25.3K ﹤0.01% 3296
2016
Q1
$60K Sell
1,722
-5,971
-78% -$193K ﹤0.01% 2982
2015
Q4
$248K Buy
7,693
+1,237
+19% +$40.1K ﹤0.01% 2293
2015
Q3
$209K Sell
6,456
-3,310
-34% -$125K ﹤0.01% 2245
2015
Q2
$404K Sell
9,766
-164
-2% -$6.91K ﹤0.01% 2074
2015
Q1
$446K Sell
9,930
-531
-5% -$22.2K ﹤0.01% 1997
2014
Q4
$391K Buy
10,461
+8,709
+497% +$319K ﹤0.01% 2187
2014
Q3
$61K Sell
1,752
-369
-17% -$13.2K ﹤0.01% 3056
2014
Q2
$75K Buy
2,121
+1,264
+147% +$42.2K ﹤0.01% 3006
2014
Q1
$28K Sell
857
-530
-38% -$20.3K ﹤0.01% 3363
2013
Q4
$58K Sell
1,387
-1,400
-50% -$57.6K ﹤0.01% 2796
2013
Q3
$111K Buy
2,787
+1,400
+101% +$58.7K ﹤0.01% 2464
2013
Q2
$57K Buy
+1,387
New +$56.2K ﹤0.01% 2668

Other funds holding HAE

Bank of Montreal's HAE Position: Q2 2026 in Review

Bank of Montreal reduced its Haemonetics (HAE) stake by 54% in Q2 2026, selling an estimated $299K and leaving 3,959 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #2782.

Bank of Montreal first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.7M in Q4 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Bank of Montreal held 3,959 shares of Haemonetics worth $297K as of Q2 2026.
  • Bank of Montreal sold 4,658 Haemonetics shares in Q2 2026, an estimated $299K.
  • Haemonetics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2782 holding.
  • Bank of Montreal first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Haemonetics position peaked at $14.7M in Q4 2020.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.